RBM10 Antibody, Biotin conjugated

Code: CSB-PA019400LD01HU
Size:
50μg
50μg100μg
US$166
Quantity:
Species Reactivity: Human
Raised in: Rabbit
Application: ELISA
For inquiries on large quantities or another requirements
Send an Inquiry
Start an on-line Chat
Online ordering is currently available for U.S. customers only. For orders outside the U.S., please kindly submit an inquiry or start a chat with us.

Product Details

Uniprot NO.
Target Names
RBM10
Alternative Names
DXS8237E antibody; G patch domain containing protein 9 antibody; G patch domain-containing protein 9 antibody; GPATC9 antibody; GPATCH9 antibody; HGNC9896 antibody; KIAA0122 antibody; MGC1132 antibody; MGC997 antibody; Rbm10 antibody; RBM10_HUMAN antibody; RNA binding motif protein 10 antibody; RNA binding protein 10 antibody; RNA binding protein S1-1 antibody; RNA-binding motif protein 10 antibody; RNA-binding protein 10 antibody; RNA-binding protein S1-1 antibody; S1-1 antibody; TARPS antibody; ZRANB5 antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human RNA-binding protein 10 protein (501-700AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Biotin
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Tested Applications
ELISA
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Usage
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Datasheet & COA

Customer Reviews and Q&A

 Customer Reviews

Target Background

Function(From Uniprot)
May be involved in post-transcriptional processing, most probably in mRNA splicing. Binds to RNA homopolymers, with a preference for poly(G) and poly(U) and little for poly(A). May bind to specific miRNA hairpins.
Gene References into Functions
  1. RBM10: Harmful or helpful-many factors to consider. PMID:29274279
  2. RBM10 mutations contribute to lung adenocarcinoma pathogenesis. PMID:28091594
  3. The high rate of TERT promoter mutations, MED12 mutations, RBM10 mutations, and chromosome 1q gain highlight their likely association with tumor virulence PMID:28634282
  4. The well-known high-fidelity RNA splice site recognition by RBM10, and probably by RBM5 and RBM6, can thus be largely rationalized by a cooperative binding action of RRM and ZnF domains PMID:29450990
  5. Our work has not only expanded the number of pre-mRNA targets for RBM10, but identified RBM10 as a novel regulator of SMN2 alternative inclusion. PMID:28728573
  6. RBM10 functions as a splicing regulator using two RNA-binding units with different specificities to promote exon skipping. PMID:28379442
  7. RNA binding motif protein 10 (RBM10) negatively regulates its own mRNA and protein expression and that of RNA binding motif protein 5 (RBM5) by promoting alternative splicing-coupled nonsense-mediated mRNA decay (AS-NMD). PMID:28586478
  8. results provide evidence that RBM10 expression, in RBM5-null tumors, may contribute to tumor growth and metastasis. Measurement of both RBM10 and RBM5 expression in clinical samples may therefore hold prognostic and/or potentially predictive value PMID:28662214
  9. RBM10-TFE3 is a recurrent gene fusion in Xp11 translocation renal cell carcinoma. PMID:28296677
  10. Xp11 translocation renal cell carcinomas with RBM10-TFE3 gene fusion demonstrating melanotic features and overlapping morphology with t(6;11) RCC. PMID:28288037
  11. RNA-binding motif 10 messenger RNA and protein were reduced in lung adenocarcinoma tissues, and RNA-binding motif 10 overexpression inhibited lung adenocarcinoma cancer cell malignant behavior in vitro. Molecularly, RNA-binding motif 10 regulates many gene pathways involving in the tumor development or progression. PMID:28347232
  12. RBM10-TFE3 fusion variant (from chromosome X paracentric inversion), therefore, appears to be a recurrent molecular event in Xp11.2 RCCs. RBM10-TFE3 fusion should be added in the list of screened fusion transcripts in targeted molecular diagnostic multiplex RT-PCR PMID:26998913
  13. RBM10 is a tumor suppressor that represses Notch signaling and cell proliferation through the regulation of NUMB alternative splicing PMID:26853560
  14. Src family tyrosine kinase signaling may regulate FilGAP through association with RBM10 PMID:26751795
  15. The ability of RBM10v1 to regulate alternative splicing depends, at least in part, on a structural alteration within the second RNA recognition motif domain, and correlates with preferential expression of the NUMB exon 11 inclusion variant. PMID:25889998
  16. RBM10 regulates alternative splicing of Fas and Bcl-x genes. PMID:24530524
  17. Antagonizes the effects of RBM5, RBM6, and RBM10 in cell colony formation. PMID:24332178
  18. This study established RBM10 as an important regulator of alternative splicing, presented a mechanistic model for RBM10-mediated splicing regulation and provided a molecular link to understanding a human congenital disorder. PMID:24000153
  19. S1-1 contains multiple nuclear localisation sequence that act cooperatively. PMID:23294349
  20. Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate. PMID:20451169
  21. From these results, it seems that the X-chromosome, through its RBM genes, plays a formerly unknown role in the regulation of programmed cell death (apoptosis) in breast cancer. PMID:16552754
  22. S1-1 constitutes hundreds of nuclear domains, which dynamically change their structures in a reversible manner; upon globally reducing RNA polymerase II transcription, S1-1 nuclear bodies enlarge and decrease in number. PMID:18315527
  23. results indicate that very few genes are involved in the last steps of the apoptotic cascade in breast cancer, among them one of the X-chromosome RBM family PMID:18820371

Show More

Hide All

Subcellular Location
Nucleus. Note=In the extranucleolar nucleoplasm constitutes hundreds of nuclear domains, which dynamically change their structures in a reversible manner. Upon globally reducing RNA polymerase II transcription, the nuclear bodies enlarge and decrease in number. They occur closely adjacent to nuclear speckles or IGCs (interchromatin granule clusters) but coincide with TIDRs (transcription-inactivation-dependent RNA domains).
Database Links

HGNC: 9896

UNIGENE: Hs.401509

KEGG: hsa:8241

STRING: 9606.ENSP00000366829

OMIM: 300080

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
No. 269, Shendun 5th Road, Donghu Hi-Tech Development Area, Hubei Province, 430206, P.R.China
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Select 0 Products